International Stem Cell Corporation to Present at 12th Annual BIO Investor Forum October 8-9th, 2013
September 26 2013 - 8:30AM
Marketwired
International Stem Cell Corporation (OTCQB: ISCO)
(www.internationalstemcell.com), a California-based biotechnology
company developing novel stem cell based therapies and biomedical
products, announced today that it will participate in the 12th
Annual BIO Investor Forum hosted by the Biotechnology Industry
Organization (BIO). The conference is being held October 8-9th,
2013, at the Palace Hotel in San Francisco, CA.
Dr. Simon Craw, Executive Vice President, will provide an
overview of the Company's business during the live presentation and
will be available to participate in one-on-one meetings with
investors who are registered to attend the conference.
Date: Wednesday, October 9, 2013 Time: 2:00 p.m. Pacific Time
Location: Palace Hotel, Presidio Room
Follow the official conference feed on Twitter, and join the
conversation by using #BIF13.
About International Stem Cell
Corporation
International Stem Cell Corporation is focused on the
therapeutic applications of human parthenogenetic stem cells
(hpSCs) and the development and commercialization of cell-based
research and cosmetic products. ISCO's core technology,
parthenogenesis, results in the creation of pluripotent human stem
cells from unfertilized oocytes (eggs). hpSCs avoid ethical issues
associated with the use or destruction of viable human embryos.
ISCO scientists have created the first parthenogenic, homozygous
stem cell line that can be a source of therapeutic cells for
hundreds of millions of individuals of differing genders, ages and
racial background with minimal immune rejection after
transplantation. hpSCs offer the potential to create the first true
stem cell bank, UniStemCell™. ISCO also produces and markets
specialized cells and growth media for therapeutic research
worldwide through its subsidiary Lifeline Cell Technology
(www.lifelinecelltech.com), and stem cell-based skin care products
through its subsidiary Lifeline Skin Care
(www.lifelineskincare.com). More information is available at
www.internationalstemcell.com or follow us on Twitter
@intlstemcell.
To receive ongoing corporate communications, please click on the
following link:
http://www.b2i.us/irpass.asp?BzID=1468&to=ea&s=0
About BIO Investor Forum
The 12th Annual BIO Investor Forum is an international investor
conference focused on private and emerging public biotech
companies. Because our mission is to support industry-wide success,
we present a broad and unbiased view of investment opportunities.
In addition, the BIO Investor Forum draws business development
executives from leading global pharmaceutical and established
biotechnology companies.
Contacts: International Stem Cell Corporation Dr. Simon
Craw Executive Vice President Phone: 760-940-6383 Email:
ir@intlstemcell.com
International Stem Cell (QB) (USOTC:ISCO)
Historical Stock Chart
From Sep 2024 to Oct 2024
International Stem Cell (QB) (USOTC:ISCO)
Historical Stock Chart
From Oct 2023 to Oct 2024